report strong one
could ask apart dental segment outperform
compani also hint upsid guidanc given
decemb strong januari order tax fx partial off-set
interest sharecount formal revis upward per
typic polici guidanc slightli street
could stock red under-perform market
theme excess high expect continu
play tool increment posit fundament
compani execut well acceler growth
said would point weak prior quarter rebound
forward look indic seem solid notabl order
commentari rais ep high end
consensu biggest factor weaker usd
estim meaning tailwind rel prior guidanc
quick take quarter beat consensu revenu
ep driven solid core growth life scienc growth
especi strong continu strength beckman
coulter rebound pall grew nearli best
sinc acquir diagnost
environment appli solut grew quarter
dental declin manag broadli posit
pharma across biolog small molecul expect difficult
market condit dental segment continu
exhibit full detail
guidanc manag re-affirmed ep
core growth interest expens expect
ep project guidanc
origin given decemb manag point
histori revis guidanc januari even though
year seem strong start fx move
favor direct tax opportun due
new account rule pension cost
corpor overhead off-set incom line
margin expans option look lower usual
exhibit full guidanc
read-through expect tomorrow play much like
dhrsolid result tepid stock reaction seem expect
across tool group simpli high right
compani data secur llc estim reuter
compani prioriti stock list
exclud amort acquir intang asset
one-tim restructur impair charg
compani data secur llc estim reuter
pleas see page rate definit import disclosur
requir analyst certif estimates/forecast
well fargo secur llc seek busi compani
cover research report result investor awar
firm may conflict interest could affect object report
investor consid report singl factor make
estactualconsyr gener expens incom pre-tax tax expens incom continu share yrseqgross bpssg bpsr bpsebitda bpsoper bpspretax bpstax bpsnet bpssegment analysisyr yrseqlif bpsenvironment appli bpstotal compani data secur llc end decemberactualin million except epsmargin analysi danah corpor
busi revenu mm coulter life cytometri cell scienc coulter chemistri lab gasmolecular small tool chair imag mostli consum restor mostli consum ortho endo implant appli sourc compani data well fargo secur llc estimateslsd single-digit msd mid single-digit hsd high single-digit dd double-digit life scienc tool servic diagnost
priorcurrentchangepriorcurrentchangenet gener expens incom pre-tax tax expens incom continu share bpssg bpsr bpsebitda bpsoper bpspretax bpstax bpsnet bpssegment analysislif bpsenvironment appli bpstotal compani data secur llc estimatesfi end million except epsmargin danah corpor
revenu pall improv fx flat expens littl wors tax compani data secur llclong-term margin expand bp per year dbsnote life scienc tool servic diagnost
summari fy end gross sell gener research oper interest expens incom pre-tax incom tax expens net incom continu non- dilut share margin analysisgross analysi y/i total share growth ebit ebitda growth ebit ebitda growth ebit ebitda appli growth ebit ebitda total growth growth growth revenu data total net cash debt ttm debt ttm flow capit free cash free cash flow per invest normal per sourc compani data secur llc estimatesin million except per sharenon- incom statementrevenu analysi corpor
price target nc
price target dcf-base wacc termin noplat growth repres
ep estim upsid rate would like come rapid improv dental segment
continu cyclic improv environmental/appli stronger-than-expect progress deal
integr new deal particularli strong synergi outlook could also drive upsid rate
downsid risk rate could caus deterior end market condit over-reach larg
deal integr risk
result impress strong two element strategi
caus us favor other tool space first think compani put disproportion focu
clinic diagnost market view favor pharma-focus strategi
certain peer second think compani continu view primarili industri
conglomer rather focus life scienc tool compani may lend well
type innov necessari drive higher growth danah busi system db
undergird entir cultur consist yield margin expans think may
much differenti investor believ particularli come top line
washington dc-base corp nyse industri conglomer focus use
continu improv techniqu improv perform acquir busi compani
product typic distinguish strong brand name innov technolog major market
posit razor/razor-blad busi model compani oper four segment life scienc
diagnost dental environment appli life scienc segment sell mass spec
chromatographi filtrat microscopi centrifug flow cytometri product pharma academia
certain industri end market diagnost sell wide varieti diagnost test equip
hospit lab refer lab patholog lab point-of-car set dental sell orthodont
implant dispos tool larger equip dental offic environment appli divid
two piec water qualiti product identif
